chrX-136548828-G-A
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_016267.4(VGLL1):c.454G>A(p.Ala152Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000264 in 1,210,413 control chromosomes in the GnomAD database, including 1 homozygotes. There are 13 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016267.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| VGLL1 | ENST00000370634.8 | c.454G>A | p.Ala152Thr | missense_variant | Exon 3 of 5 | 1 | NM_016267.4 | ENSP00000359668.3 | ||
| VGLL1 | ENST00000440515.5 | c.346G>A | p.Ala116Thr | missense_variant | Exon 2 of 4 | 3 | ENSP00000398360.1 | |||
| VGLL1 | ENST00000456412.1 | c.41-1940G>A | intron_variant | Intron 1 of 2 | 3 | ENSP00000388868.1 |
Frequencies
GnomAD3 genomes AF: 0.0000267 AC: 3AN: 112161Hom.: 0 Cov.: 23 show subpopulations
GnomAD2 exomes AF: 0.000158 AC: 29AN: 183309 AF XY: 0.000133 show subpopulations
GnomAD4 exome AF: 0.0000264 AC: 29AN: 1098252Hom.: 1 Cov.: 32 AF XY: 0.0000330 AC XY: 12AN XY: 363606 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000267 AC: 3AN: 112161Hom.: 0 Cov.: 23 AF XY: 0.0000291 AC XY: 1AN XY: 34335 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.454G>A (p.A152T) alteration is located in exon 3 (coding exon 2) of the VGLL1 gene. This alteration results from a G to A substitution at nucleotide position 454, causing the alanine (A) at amino acid position 152 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at